salmeterol xinafoate has been researched along with Lung Injury, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooke, MW; Gao, F; Gates, S; Holloway, B; Knox, C; Lamb, SE; Marzouk, J; McAuley, DF; Park, D; Perkins, GD; Ryan, J; Thickett, DR | 1 |
| Budinger, GR; Mutlu, GM | 1 |
| Alderson, D; Cooke, MW; Gao, F; Gates, S; Lamb, SE; Mistry, D; Park, D; Perkins, GD; Thickett, DR | 1 |
2 trial(s) available for salmeterol xinafoate and Lung Injury, Acute
| Article | Year |
|---|---|
The beta agonist lung injury trial prevention. A randomized controlled trial.
Topics: Acute Lung Injury; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Drug Administration Schedule; Elective Surgical Procedures; Esophagectomy; Female; Humans; Intention to Treat Analysis; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Salmeterol Xinafoate; Treatment Outcome | 2014 |
The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol.
Topics: Acute Lung Injury; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Albuterol; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Esophagectomy; Humans; Placebo Effect; Quality of Life; Research Design; Respiration, Artificial; Salmeterol Xinafoate; Survival Rate; Time Factors; Treatment Outcome; United Kingdom | 2011 |
1 other study(ies) available for salmeterol xinafoate and Lung Injury, Acute
| Article | Year |
|---|---|
β2-agonists and acute respiratory distress syndrome.
Topics: Acute Lung Injury; Adrenergic beta-2 Receptor Agonists; Albuterol; Female; Humans; Male; Perioperative Care; Postoperative Complications; Salmeterol Xinafoate | 2014 |